Brazilian scientists conducted the first research project to evaluate the immunity induced in an actual group of vaccinated ...
A submission to the US Food and Drug Administration (FDA) requesting an Emergency Use Authorization (EUA) of a 10-µg booster dose of Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for ...
A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less ...
The original COVID-19 vaccines made by Pfizer and Moderna no longer are authorized in the U.S., the Food and Drug Administration announced on Tuesday, April 18. Now, both companies’ newer COVID ...
Aiming to provide additional protection for Americans against the coronavirus over the upcoming flu season, the FDA authorized new versions of Pfizer and Moderna’s Covid-19 vaccines. WASHINGTON (CN) — ...
March 26, 2024 – The FDA has approved a new antibody treatment to help prevent COVID-19 in those who are most at risk from the virus. In its announcement, the agency explained that the new ...
T he COVID vaccine may be linked to a small increase in stroke risk when given with a high-dose flu shot, primarily in ...
“This decision comes at a time when Covid-19 cases are once again climbing,” Bourla said The US Food and Drug Administration (FDA) approved the latest versions of COVID-19 vaccines developed ...
New, modified versions of Pfizer’s and Moderna’s existing COVID-19 vaccines received a green light from the Food and Drug Administration to be used as booster shots on Wednesday, Aug. 31.
Last fall, U.S. health officials authorized new COVID-19 booster shots designed to target the original strain of the coronavirus and some of the Omicron subvariants that were circulating around ...
Opinions expressed by Forbes Contributors are their own. I am a writer, journalist, professor, systems modeler, computational and digital health expert, avocado-eater, and entrepreneur, not always ...
Brazilian drug regulator Anvisa on Monday (Jul. 24) gave its full approval for the bivalent Comirnaty COVID-19 vaccine by Pfizer. The jab is recommended for the prevention of COVID-19 and may now ...